Author:
Budko Hanna,Ivakhniuk Tetyana,Sushchenko Svitlana,Kozyr Natalia
Reference45 articles.
1. Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022). The immune response as a double-edged sword: The lesson learned during the COVID-19 pandemic. Immunology, 167(3), 287-302. doi:10.1111/imm.13564
2. Agrawal, D., Agrawal, N., Sarangdhar, S., Kumari, V., Narain, N., Lader, N., Pal, S., & Pradhan, S. (2021). Role of altered fractionation in radiation therapy with or without chemotherapy in management of carcinoma cervix: Time to revisit in the current COVID-19 pandemic. Clinical Cancer Investigation Journal, 10(2), 53-53.
3. Alahyari, S., Rajaeinejad, M., Jalaeikhoo, H., & Amani, D. (2022). Regulatory T cells in immunopathogenesis and severity of COVID-19: A systematic review. Archives of Iranian Medicine, 25(2), 127-132. doi:10.34172/aim.2022.22
4. Aldahlawi, A. M., & Zaher, K. S. A. (2021). Spotlight on Immunity against COVID-19 with Emphasis on Cytokine Storm. Pharmacophore, 12(2), 57-65.
5. Al-Hamamy, H. R. (2022). COVID-19: Immune response. Research Journal of Pharmacy and Technology, 467-470. doi:10.52711/0974-360x.2022.00076